Comparison 9. Oral compared to intramuscular dexamethasone.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Return visits or (re)admissions or both by inpatient/outpatient	3		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
1.1 Outpatient	3	440	Risk Ratio (M‐H, Random, 95% CI)	0.81 [0.58, 1.12]
2 Improvement (at 24 hours) by inpatient/outpatient	1	95	Risk Ratio (M‐H, Random, 95% CI)	1.07 [0.95, 1.19]
2.1 Outpatient	1	95	Risk Ratio (M‐H, Random, 95% CI)	1.07 [0.95, 1.19]
3 Additional treatments: antibiotics	1	277	Risk Ratio (M‐H, Random, 95% CI)	0.14 [0.02, 1.15]
4 Additional treatments: epinephrine	2	372	Risk Ratio (M‐H, Random, 95% CI)	0.94 [0.71, 1.24]
5 Additional treatments: mist tent	1	277	Risk Ratio (M‐H, Random, 95% CI)	1.34 [0.31, 5.89]
6 Additional treatments: supplemental glucocorticoids	1	277	Risk Ratio (M‐H, Random, 95% CI)	1.10 [0.50, 2.41]